Metraipolis › archive › dc_ae5d25bda19c

Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named "Regimen C" for pre-XDR… — Europe PMC PMID:42638850

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42638850
DOI
10.3389/ftubr.2025.1718997
License (as archived)
solo-consultazione
Archived
2026-11-06T20:10:54.666Z
SHA-256 of the archived text
29e0dee4fcdcfe9030c068a4d30617b48b7065d072619492db3476064ad68447
Stable URL of this page
https://metraipolis.com/documento/dc_ae5d25bda19c

How to cite

Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named "Regimen C" for pre-XDR… — Europe PMC PMID:42638850 — Europe PMC (en), https://europepmc.org/article/MED/42638850 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ae5d25bda19c (Metraipolis archive dc_ae5d25bda19c, sha256 29e0dee4fcdcfe9030c068a4d30617b48b7065d072619492db3476064ad68447)
BibTeX
@misc{dcae5d25bda19c,
  title = {Evaluation of a short, all oral treatment regimen including bedaquiline, delamanid, linezolid, clofazimine, and pyrazinamide named "Regimen C" for pre-XDR… — Europe PMC PMID:42638850},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42638850},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ae5d25bda19c; sha256 29e0dee4fcdcfe9030c068a4d30617b48b7065d072619492db3476064ad68447},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42638850. Agents can read the archived copy with the MCP tool read_document.